Print

Spermatech Licenses Dotmatics' Platform to Support Their Male Contraceptive Research  
10/30/2012 7:22:25 AM

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics Limited, a leading supplier of scientific informatics solutions to the Biotech industry, announced today that Spermatech AS, an early drug discovery company based in Oslo, has selected the Dotmatics Platform as their central system to manage and analyse their scientific data.